Swedish investment firm EQT will take Dechra Pharmaceuticals DPH.L private in a deal with an equity value of 4.46 billion pounds ($5.62 billion), the British veterinary drugmaker said on Friday.
Under the terms of the deal, each Dechra shareholder will receive 3,875 pence in cash, which represents a premium of about 44% to the last closing price before the offer period commenced.
The firms had been in talks for a deal since April.
The enterprise value of the deal is 4.88 billion pounds.
https://www.nasdaq.com/articles/eqt-to-take-uks-dechra-pharma-private-for-$5.6-bln
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.